Galina Selivanova

6PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 16, 2025
Reply to 'Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies'.

Sylvain Peuget, Galina Selivanova

|Jan 29, 2024
Translating p53-based therapies for cancer into the clinic.

Sylvain Peuget, Xiaolei Zhou, Galina Selivanova

|May 04, 2023
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation.

Sylvain Peuget, Galina Selivanova

|Sep 22, 2022
Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246.

Xiaolei Zhou, Gema Sanz Santos, Yue Zhan

|Jul 25, 2022
Decreased DNA Damage and Improved p53 Specificity of RITA Analogs.

Yue Zhan, Xiaolei Zhou, Sylvain Peuget

|Oct 13, 2021
p53-Dependent Repression: DREAM or Reality?

Sylvain Peuget, Galina Selivanova

Pageof 1